Contribution of microRNA-30d to the prevention of the thyroid cancer occurrence and progression: mechanism and implications

Thyroid Cancer is a major endocrine tumor and represents an emerging health problem worldwide. MicroRNAs (miRNAs) have been addressed to participate in the pathogenesis and progression of thyroid Cancer. However, it remains largely unknown what functions miR-30d may exert on thyroid Cancer. This study, herein, aimed to identify the functional significance and machinery of miR-30d in the progression of thyroid Cancer. MiR-30b presented aberrant low expression and Ubiquitin-Specific Protease 22 (USP22) exhibited aberrant high expression in thyroid Cancer tissues and cells. The current study proposed the possible machinery that miR-30d could target and negatively regulate USP22. Additionally, USP22 could enhance the stability of SIRT1 by inducing deubiquitination which consequently contributed to FOXO3a deacetylation-induced PUMA repression. Responding to the gain- or loss-of-function of miR-30d and/or USP22, behaviors of thyroid Cancer cells were altered. Accordingly, miR-30d inhibited proliferation and promoted Apoptosis of thyroid Cancer cells by suppressing USP22 through SIRT1/FOXO3a/PUMA axis. The effects of miR-30d and USP22-mediated SIRT1/FOXO3a/PUMA axis on thyroid tumorigenesis were finally validated in murine models. We ultimately confirmed the anti-proliferative and pro-apoptotic effect of miR-30d via suppressing USP22 through in vivo findings. Conclusively, our findings highlight that the occurrence and progression of thyroid Cancer can be suppressed by miR-30d-mediated inhibition of USP22 via the SIRT1/FOXO3a/PUMA axis, which provides a attractive therapeutic target for thyroid Cancer treatment.

Forkhead box protein O3; MicroRNA-30d; P53-up-regulated modulator of apoptosis; Sirtuin-1; Thyroid cancer; Ubiquitin-specific protease 22.